Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 31, 2025
The Good Feet Store Re-Opens in Louisville, Helping Local Residents and Workforce Live the Life They Love
EIN Presswire
·
March 31, 2025
The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Opening of its Relocated Louisville Location LOUISVILLE, KY, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- The Good Feet Store, recognized nationally as the market- …
First Responder Neurofeedback, Inc. Launches Nationwide to Enhance Mental Health and Well-Being for First Responders
EIN Presswire
·
March 31, 2025
Jennifer Tierney Appointed as Executive Director to Lead Strategic Planning and Program Development DENVER, CO, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- First Responder Neurofeedback, Inc., a nonprofit organization committed to supporting the …
Ayushman Hair Centre Launches New Website for Hair Restoration Services
EIN Presswire
·
March 31, 2025
NEW DELHI, DELHI, INDIA, March 31, 2025 /EINPresswire.com/ -- Ayushman Hair Centre, a leading hair restoration clinic, has recently launched a new website to provide a convenient and accessible platform for their clients. The website offers a wide range …
Boon-Chapman Strengthens Leadership Team with Appointment of New General Counsel
EIN Presswire
·
March 31, 2025
AUSTIN, TX, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Boon-Chapman, a leader in claims administration, cost containment, and care navigation, is pleased to announce the appointment of Tim McConville as General Counsel, effective March 31, 2025. …
Planet TV Studios ‘New Frontiers’ Episode on Mirion Technologies, Accelerating Advancements in Precision Medicine, Airing Q2 2025: The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios
EIN Presswire
·
March 31, 2025
Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. Mirion Technologies, Inc. in New Frontiers Episode Airing Q2 2025 on Bloomberg. ATLANTA, GA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Planet TV Studios is …
Biomed Industries CEO to Chair NeuroSciences 2025 and Present Breakthrough Research on Alzheimer’s Disease and Obesity
EIN Presswire
·
March 31, 2025
Biomed Industries, Inc. CEO to Chair NeuroSciences 2025 and Present Groundbreaking Research on Alzheimer’s, Obesity, and Rett Syndrome SAN JOSE, CA, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- Biomed Industries, Inc. (Biomed) announced today …
Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market
GlobeNewswire
·
March 31, 2025
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be held Tuesday, April 1st at 11:00 a.m. Eastern Time …
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 31, 2025
Transformational 2024: successfully advanced from preclinical to clinical stage company Strengthened leadership team to drive growth and advance clinical development Investigational Device Exemption (IDE) approval for continuous blood glucose monitoring ( …
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
GlobeNewswire
·
March 31, 2025
PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host a fireside chat at the 2025 RBC Capital Markets …
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 31, 2025
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing Preparations for Phase 1/2 clinical trial in Australia …
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
GlobeNewswire
·
March 31, 2025
NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing …
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire
·
March 31, 2025
Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc …
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
GlobeNewswire
·
March 31, 2025
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Zevra Therapeutics Files Preliminary Proxy
GlobeNewswire
·
March 31, 2025
Confirms Receipt of Two Director Nominees from Daniel J. Mangless Stockholders Are Not Required to Take Action at This Time CELEBRATION, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (Nasdaq:GS ZVRA) (“Zevra,” or the “Company”), a …
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
GlobeNewswire
·
March 31, 2025
Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome (PWS), with meaningful reductions in hyperphagia (up to a 16-point HQ-CT reduction, with an average reduction of …
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
GlobeNewswire
·
March 31, 2025
Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 including: FDA meeting anticipated in first half 2025 to discuss icovamenib late-stage …
World’s First: NOCCI and ERIC Introduce Dimensional Energy Work to Activate the Pineal Gland and Awaken the Third Eye
EIN Presswire
·
March 31, 2025
A Breakthrough in Human Consciousness: Remote Energy Work Unlocks the Third Eye and Initiates Dimensional Contact MUNICH, BAVARIA, GERMANY, March 31, 2025 /EINPresswire.com/ -- International spiritual leaders NOCCI and her soul partner ERIC have co- …
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
GlobeNewswire
·
March 31, 2025
BOSTON and ATHENS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, today announced that the Company’s Co-Founder and Chief Scientific Officer, Dr. …
Revolution Medicines to Participate in April 2025 Investor Conferences
GlobeNewswire
·
March 31, 2025
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., …
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
GlobeNewswire
·
March 31, 2025
- Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® capsule, to subcutaneous administration of PG-102 - - Announced preclinical data demonstrating successful oral …